In line with PitchBook analysts’ predictions, PE pharma services dealmaking accelerated rapidly in Q3. PitchBook’s Q3 2024 Pharma Services PE Update records an estimated 110 deals in the quarter, a pace not seen since late 2021 and early 2022. PE dealmaking in general has accelerated with an increasingly favorable financing environment, and pharma services in particular has become a high priority target for many healthcare PE investors over the past few years. The report predicts that the pace set in Q3 will continue into 2025, with site management organizations and commercialization & medical affairs among the categories to watch next year.
Read the full article: PE Pharma Services Dealmaking Hits Pace Not Seen Since 2021 //
Source: https://pitchbook.com/news/reports/q3-2024-pharma-services-pe-update